Log in
Forgot password


SPONSORS

                                         

                                          

OctOBER 28 - DAY 1

8:15-9:00

Continental Breakfast

8:45-9:00

Welcome & Announcements


Ron Dolle, Director of the Center for Drug Discovery

Washington University of St. Louis

9:00 – 10:00

Opening Keynote: Preclinical Innovations

Daniel Nomura

University of California, Berkeley

Frontier Medicine
 
 
10:00 - 10:30 Coffee Break  
     

10:30 - 12:00

Session 1: New Approach Methods (NAMs) in DDD


10:30

Title TBD

Jack Song, University of Alabama, Birmingham
 11:00

Qualification of Complex in vitro Models for Regulatory Decision Making

Speaker TBD, Critical Path Institute
 


11:30

A Generalizable Deep Learning Framework for Protein-Ligand Affinity Ranking

Benjamin P. Brown, MD, PhD

Dept. of Pharmacology and Center for AI in Protein Dynamics, Vanderbilt University
 
 

12:00 - 1:15

LUNCH (included)
 
 

1:15 - 2:45

Session 2: Advancing Your Innovation
1:15 

Title TBD

Gary Robinson, NIH/NCI

  


1:45

Title TBD

Shripad Bhagwat, Needleman Program for Innovation and Commercialization at WUSTL
 2:15

Special Topics in Patent Law for Academic Researchers

Brian Shortel, Ballard Spahr LLP
     

2:45 - 3:15

Coffee Break
     

3:15 - 4:15

Session 3: Lessons in Perseverance


3:30

The Development of mGlu4 Positive Allosteric Modulators for the Treatment of Parkinson’s Disease

Colleen Niswender, Vanderbilt University
 4:00

Title TBD

Guillermo Vela, NeuScience
 
     

4:15 - 4:45

Session 4: Posters Lightning Round 

Selected trainees will have 5 minutes to present their posters on stage
     
4:45 - 5:15  Poster Mounting   
     

5:15 - 7:15

Welcome Reception with Posters (poster judging)

Oct. 29 - DAY 2

8:15-9:00

Continental Breakfast

9:00 – 10:30

Session 5: Funding Sources for 2026 and Beyond


9:00

The Translational Therapeutics Accelerator (TRxA): Maturing Your Academic Asset In University Walls

Maaike Everts, Critical Path Institute
 9:20

Due Diligence?  What Does “Good” Look Like & How Might We Prepare?

Michael Myers, PhD, Associate Vice President & Head of Due Diligence, Eli Lilly & Co.

  
 9:40

Title TBD

Ryan Sullivan, Curie.Bio

  
10:00 Panel Discussion  

   
10:30 - 11:00 

Coffee Break

  
     

11:00 – 11:30

Session 6: IMPACT Lightning Round 

Three 10-minute program overviews, selected from IMPACT database submissions
 11:00

Speaker 1

  
 11:10

Speaker 2

  
 11:20

Speaker 3

  
     
11:30 - 12:00  Session 7: Awards & Recognitions  
 


Paige Vinson, ADDC / Southern Research

  
   
12:00 - 1:15

LUNCH (included)

  
 
 

1:15 - 2:15

Session 8: Novel Approaches to Discovery 


1:15

Encoding Chemicals and Assays with DNA: Applications in Drug Discovery and Development

Casey Krusemark, Purdue University
1:45

Title TBD

Vsevolod Katritch, University of Southern California

  
   
2:15 - 2:45  Coffee Break  
   

2:45 – 3:45

Closing Keynote:  Learning From the Past, Looking to the Future 

Matthew Hall, NIH/NCATS 

3:45 – 4:00

Closing Remarks / Adjourn


Ron Dolle, Washington University of St. Louis
 
 
4:30 - 6:30 Biogenerator Startup Incubator Reception   



Jim McCarter

Sr. Managing Director, Biogenerator Ventures

Sr. Vice President BioSTL
 


Crystal Winkeler

Managing Director, Biogenerator Ventures

  

KEYNOTE SPEAKERs



Contact us

Powered by Wild Apricot Membership Software